Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARD
7476
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $663K | ﹤0.01% |
38,495
+2,627
| +7% | +$43.6K |
|
7477
Crinetics Pharmaceuticals
CRNX
$8.99B
| $661K | ﹤0.01% |
46,864
+7,762
| +20% | +$108K |
|
7478
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$590M
| $661K | ﹤0.01% |
21,198
+6,550
| +45% | +$196K |
|
7479
CALL
Matsons
MATX
$6.5B
| $661K | ﹤0.01% |
+11,600
| New | +$633K |
|
7480
CALL
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $661K | ﹤0.01% |
14,000
-15,900
| -53% | -$699K |
|
7481
BCE
BCE
$21.9B
| $660K | ﹤0.01% |
15,435
-62,337
| -80% | -$2.67M |
|
7482
CALL
Community Bank
CBU
$3.46B
| $660K | ﹤0.01% |
10,600
+6,100
| +136% | +$374K |
|
7483
KT
KT
$9.11B
| $660K | ﹤0.01% |
59,936
+49,883
| +496% | +$526K |
|
7484
Viper Energy
VNOM
$15.2B
| $660K | ﹤0.01% |
56,802
-9,741
| -15% | -$94.7K |
|
7485
PUT
Wrap Technologies
WRAP
$105M
| $660K | ﹤0.01% |
136,700
-14,200
| -9% | -$82.4K |
|
|
CLCT
7486
DELISTED
Collectors Universe
CLCT
| $660K | ﹤0.01% |
8,757
+431
| +5% | +$29.2K |
|
7487
CALL
Mativ Holdings
MATV
$674M
| $659K | ﹤0.01% |
+16,400
| New | +$588K |
|
7488
CALL
Alpha Pro Tech
APT
$55.4M
| $658K | ﹤0.01% |
59,000
-53,200
| -47% | -$718K |
|
7489
PUT
Marcus Corp
MCS
$925M
| $658K | ﹤0.01% |
48,800
-89,800
| -65% | -$909K |
|
7490
CALL
W.R. Berkley
WRB
$26.2B
| $658K | ﹤0.01% |
22,275
-6,075
| -21% | -$175K |
|
|
VNE
7491
CALL
DELISTED
Veoneer, Inc.
VNE
| $658K | ﹤0.01% |
30,900
+14,700
| +91% | +$278K |
|
|
BPY
7492
CALL
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $658K | ﹤0.01% |
45,500
-391,200
| -90% | -$5.74M |
|
7493
PUT
Alto Ingredients
ALTO
$324M
| $657K | ﹤0.01% |
121,000
+42,800
| +55% | +$297K |
|
7494
CALL
Digimarc Corp
DMRC
$169M
| $657K | ﹤0.01% |
13,900
+1,000
| +8% | +$39.1K |
|
7495
PUT
iShares MSCI Spain ETF
EWP
$2.22B
| $657K | ﹤0.01% |
24,300
+8,300
| +52% | +$207K |
|
7496
PUT
El Pollo Loco
LOCO
$473M
| $657K | ﹤0.01% |
36,300
+20,800
| +134% | +$350K |
|
7497
CALL
American Superconductor
AMSC
$1.55B
| $656K | ﹤0.01% |
28,000
-48,400
| -63% | -$858K |
|
7498
Blink Charging
BLNK
$85.9M
| $656K | ﹤0.01% |
+15,337
| New | +$303K |
|
7499
Vir Biotechnology
VIR
$1.56B
| $656K | ﹤0.01% |
24,486
-46,153
| -65% | -$1.5M |
|
|
RFUN
7500
DELISTED
RiverFront Dynamic Unconstrained Income
RFUN
| $656K | ﹤0.01% |
25,435
-5,131
| -17% | -$131K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.